FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4320180329> ?p ?o ?g. }

• W4320180329 endingPage "154374" @default.
• W4320180329 startingPage "154374" @default.
• W4320180329 abstract "GPRASP1 (G-protein-coupled receptor-associated sorting protein 1) plays an important role in tumorigenesis. However, GPRASP1 specific role has not been clearly clarified in cancer, particularly in pancreatic cancer(PC). Firstly, we utilized pan-cancer analysis based on RNA sequencing data from TCGA (The Cancer Genome Atlas) to evaluate the expression pattern and immunological role of GPRASP1. Then, through multiple transcriptome datasets (TCGA and Gene Expression Omnibus (GEO)) and multi-omics (RNA-seq, DNA methylation, copy number variations (CNV), somatic mutation data) in-depth analysis, we comprehensively explore the relationship of GPRASP1 expression with clinicopathologic characteristics, clinical outcomes, CNV, and DNA methylation in pancreatic cancer. Additionally, we employed immunohistochemistry (IHC) to further confirm GPRASP1 expression pattern between PC tissues and paracancerous tissues. Lastly, we systematically associated the GPRASP1 with immunological properties from numerous perspectives, such as immune cell infiltration, immune-related pathways, immune checkpoint inhibitors, immunomodulators, immunogenicity, and immunotherapy. Through pan-cancer analysis, we identified that GPRASP1 plays a critical role in the occurrence and prognosis of PC, and is closely related to immunological characteristics in PC. IHC analysis confirmed that GPRASP1 is significantly down-regulated in PC compared with normal tissues. The expression of GPRASP1 is significantly negatively correlated with clinical features (histologic grade, T stage, and TNM stage), and is an independent predictor of favorable prognosis, regardless of other clinicopathological features (HR: 0.69, 95% CI 0.54–0.92, p= 0.011). The etiological investigation found that the abnormal expression of GPRASP1 was related to DNA methylation and CNV frequency. Subsequently, the high expression of GPRASP1 was significantly correlated with immune cell infiltration (CD8 + T cell, tumor-infiltrating lymphocyte(TIL)), immune-related pathways(cytolytic activity, check-point, human leukocyte antigen (HLA)), immune checkpoint inhibitors (CTLA4, HAVCR2, LAG3, PDCD1 and TIGIT), immunomodulators ( CCR4/5/6, CXCL9, CXCR4/5), and immunogenicity(immune score, neoantigen, TMB(tumor mutation burden)). Finally, IPS (immunophenoscore) and TIDE (tumor immune dysfunction and exclusion) analysis demonstrated that GPRASP1 expression levels can accurately predict the immunotherapeutic response. GPRASP1 is a promising candidate biomarker that plays a role in the occurrence, development, and prognosis of PC. Evaluating GPRASP1 expression will aid in the characterization of tumor microenvironment (TME) infiltration and orient more efficient immunotherapy strategies." @default.
• W4320180329 created "2023-02-13" @default.
• W4320180329 creator A5019785879 @default.
• W4320180329 creator A5048955103 @default.
• W4320180329 creator A5060120548 @default.
• W4320180329 creator A5062385774 @default.
• W4320180329 creator A5068327587 @default.
• W4320180329 creator A5072293078 @default.
• W4320180329 date "2023-03-01" @default.
• W4320180329 modified "2023-10-09" @default.
• W4320180329 title "Comprehensive pan-cancer analysis of role of GPRASP1, associated with clinical outcomes, immune microenvironment, and immunotherapeutic efficiency in pancreatic cancer" @default.
• W4320180329 cites W1607316259 @default.
• W4320180329 cites W1986895634 @default.
• W4320180329 cites W1988546088 @default.
• W4320180329 cites W2795867722 @default.
• W4320180329 cites W2949273159 @default.
• W4320180329 cites W2976924121 @default.
• W4320180329 cites W2999417355 @default.
• W4320180329 cites W3012468089 @default.
• W4320180329 cites W3041538945 @default.
• W4320180329 cites W3047300873 @default.
• W4320180329 cites W3097074834 @default.
• W4320180329 cites W3109345582 @default.
• W4320180329 cites W3113686836 @default.
• W4320180329 cites W3116290443 @default.
• W4320180329 cites W3119281926 @default.
• W4320180329 cites W3120831468 @default.
• W4320180329 cites W3153075376 @default.
• W4320180329 cites W3172911572 @default.
• W4320180329 cites W3176606010 @default.
• W4320180329 cites W3181728629 @default.
• W4320180329 cites W3181865559 @default.
• W4320180329 cites W3196112679 @default.
• W4320180329 cites W4210460813 @default.
• W4320180329 cites W4220857437 @default.
• W4320180329 cites W4229053922 @default.
• W4320180329 cites W4281386966 @default.
• W4320180329 cites W4283219913 @default.
• W4320180329 doi "https://doi.org/10.1016/j.prp.2023.154374" @default.
• W4320180329 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36801507" @default.
• W4320180329 hasPublicationYear "2023" @default.
• W4320180329 type Work @default.
• W4320180329 citedByCount "0" @default.
• W4320180329 crossrefType "journal-article" @default.
• W4320180329 hasAuthorship W4320180329A5019785879 @default.
• W4320180329 hasAuthorship W4320180329A5048955103 @default.
• W4320180329 hasAuthorship W4320180329A5060120548 @default.
• W4320180329 hasAuthorship W4320180329A5062385774 @default.
• W4320180329 hasAuthorship W4320180329A5068327587 @default.
• W4320180329 hasAuthorship W4320180329A5072293078 @default.
• W4320180329 hasBestOaLocation W43201803291 @default.
• W4320180329 hasConcept C104317684 @default.
• W4320180329 hasConcept C121608353 @default.
• W4320180329 hasConcept C143998085 @default.
• W4320180329 hasConcept C150194340 @default.
• W4320180329 hasConcept C162317418 @default.
• W4320180329 hasConcept C190727270 @default.
• W4320180329 hasConcept C203014093 @default.
• W4320180329 hasConcept C204232928 @default.
• W4320180329 hasConcept C2777701055 @default.
• W4320180329 hasConcept C2780210213 @default.
• W4320180329 hasConcept C33288867 @default.
• W4320180329 hasConcept C502942594 @default.
• W4320180329 hasConcept C530470458 @default.
• W4320180329 hasConcept C54355233 @default.
• W4320180329 hasConcept C555283112 @default.
• W4320180329 hasConcept C71924100 @default.
• W4320180329 hasConcept C86803240 @default.
• W4320180329 hasConcept C8891405 @default.
• W4320180329 hasConceptScore W4320180329C104317684 @default.
• W4320180329 hasConceptScore W4320180329C121608353 @default.
• W4320180329 hasConceptScore W4320180329C143998085 @default.
• W4320180329 hasConceptScore W4320180329C150194340 @default.
• W4320180329 hasConceptScore W4320180329C162317418 @default.
• W4320180329 hasConceptScore W4320180329C190727270 @default.
• W4320180329 hasConceptScore W4320180329C203014093 @default.
• W4320180329 hasConceptScore W4320180329C204232928 @default.
• W4320180329 hasConceptScore W4320180329C2777701055 @default.
• W4320180329 hasConceptScore W4320180329C2780210213 @default.
• W4320180329 hasConceptScore W4320180329C33288867 @default.
• W4320180329 hasConceptScore W4320180329C502942594 @default.
• W4320180329 hasConceptScore W4320180329C530470458 @default.
• W4320180329 hasConceptScore W4320180329C54355233 @default.
• W4320180329 hasConceptScore W4320180329C555283112 @default.
• W4320180329 hasConceptScore W4320180329C71924100 @default.
• W4320180329 hasConceptScore W4320180329C86803240 @default.
• W4320180329 hasConceptScore W4320180329C8891405 @default.
• W4320180329 hasLocation W43201803291 @default.
• W4320180329 hasLocation W43201803292 @default.
• W4320180329 hasOpenAccess W4320180329 @default.
• W4320180329 hasPrimaryLocation W43201803291 @default.
• W4320180329 hasRelatedWork W1998349112 @default.
• W4320180329 hasRelatedWork W2024490794 @default.
• W4320180329 hasRelatedWork W2046964473 @default.
• W4320180329 hasRelatedWork W2052355316 @default.
• W4320180329 hasRelatedWork W2054863651 @default.
• W4320180329 hasRelatedWork W2107880877 @default.
• W4320180329 hasRelatedWork W2128056428 @default.

• next